NCT03639883View on ClinicalTrials.gov

A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

December 4, 2019

Study Completion Date

December 19, 2019

Conditions
ScarIncisionAbdominalWound (Morphologic Abnormality)
Interventions
DRUG

AIV001

Intradermal injection

Trial Locations (2)

92121

Cosmetic Laser Dermatology, San Diego

95630

Kaufman and Davis Plastic Surgery, Folsom

Sponsors
All Listed Sponsors
lead

AiViva BioPharma, Inc.

INDUSTRY

NCT03639883 - A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision | Biotech Hunter | Biotech Hunter